Literature DB >> 3081041

The expressed human hepatic receptor for low-density lipoproteins differs from the fibroblast low-density lipoprotein receptor.

J M Hoeg, S J Demosky, K J Lackner, J C Osborne, C Oliver, H B Brewer.   

Abstract

The role of the cellular receptor for the low-density lipoproteins (LDL) in cholesterol transport was initially defined through the study of nonhepatic cells in vitro. Since the liver is central in plasma lipoprotein metabolism, an investigation of hepatic lipoprotein receptors is important for understanding normal lipoprotein transport. Utilizing human hepatic and fibroblast membranes, the characteristics of receptors for LDL from hepatic and nonhepatic tissues were directly compared. Human hepatic membranes reversibly bound LDL within 5 min. Although both fibroblast and hepatic membranes saturably bound LDL at 37 degrees C, the fibroblast LDL receptor affinity (Kd = 2.5 X 10(-8) M) and number (5.5 X 10(12) sites/mg membrane protein) were greater than the hepatic receptor affinity (Kd = 10.8 X 10(-8) M) and number (0.5 X 10(12) sites/mg membrane protein). In contrast to the fibroblast LDL receptor which was unable to bind LDL in the presence of EDTA, the hepatic LDL receptor binding of LDL was only partially blocked by EDTA. The binding of LDL to its hepatic receptor is highly temperature-dependent, and studies utilizing both radiolabeled LDL and colloidal gold-labeled LDL indicate that little, if any, binding of LDL hepatic membranes occur at 0-4 degrees C. The hepatic membrane receptor(s) (Mr approximately equal to 270 000 and 330 000) differ from that of the fibroblast LDL receptor (Mr approximately equal to 130 000) and these proteins are present in hepatic membranes from a patient lacking the fibroblast LDL receptor. These data indicate that an expressed hepatic LDL receptor has unique properties different from those of the fibroblast LDL receptor and that the expressed protein(s) is genetically distinct from the fibroblast receptor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081041     DOI: 10.1016/0005-2760(86)90312-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  In vivo regulation of human mononuclear leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase. Decreased enzyme catalytic efficiency in familial hypercholesterolemia.

Authors:  P W Stacpoole; D M Bridge; I M Alvarez; R B Goldberg; H J Harwood
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

2.  Low-density-lipoprotein receptors in different rabbit liver cells.

Authors:  M S Nenseter; O Myklebost; R Blomhoff; C A Drevon; A Nilsson; K R Norum; T Berg
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

3.  Low density lipoprotein receptor-binding activity in human tissues: quantitative importance of hepatic receptors and evidence for regulation of their expression in vivo.

Authors:  M J Rudling; E Reihnér; K Einarsson; S Ewerth; B Angelin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

4.  Lipoprotein binding to cultured human hepatoma cells.

Authors:  F Krempler; G M Kostner; W Friedl; B Paulweber; H Bauer; F Sandhofer
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

5.  Purification of low density lipoprotein receptor from liver and its quantification by anti-receptor monoclonal antibodies.

Authors:  E Gherardi; N Brugni; D E Bowyer
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

6.  Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor.

Authors:  J Herz; U Hamann; S Rogne; O Myklebost; H Gausepohl; K K Stanley
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.